Glen Eagle Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Glen Eagle Advisors, LLC

  • $546 Billion
  • Q2 2024

A detailed history of Glen Eagle Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 136 shares of REGN stock, worth $156,844. This represents 0.03% of its overall portfolio holdings.

Number of Shares
136
Previous 45 202.22%
Holding current value
$156,844
Previous $15.5 Million 822.43%
% of portfolio
0.03%
Previous 0.01%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $80,371 - $97,478
91 Added 202.22%
136 $143 Million
Q1 2024

Jul 03, 2024
BUY
$902.69 - $993.35 $113,738 - $125,162
126 New
126 $121 Million
Q1 2023

Aug 13, 2024
SELL
$680.49 - $826.97 $680 - $826
-1 Reduced 0.78%
128 $105 Million
Q4 2022

Aug 13, 2024
BUY
$705.89 - $766.39 $705 - $766
1 Added 0.78%
129 $93.1 Million
Q3 2022

Aug 13, 2024
SELL
$573.97 - $724.32 $4,591 - $5,794
-8 Reduced 5.88%
128 $88.2 Million
Q3 2021

Aug 13, 2024
SELL
$574.03 - $680.96 $2,870 - $3,404
-5 Reduced 3.55%
136 $82.3 Million
Q2 2021

Aug 13, 2024
SELL
$472.8 - $558.54 $28,368 - $33,512
-60 Reduced 29.85%
141 $78.8 Million
Q1 2021

Aug 13, 2024
SELL
$446.73 - $548.2 $22,336 - $27,410
-50 Reduced 19.92%
201 $95.1 Million
Q4 2020

Aug 13, 2024
BUY
$478.3 - $607.98 $59,787 - $75,997
125 Added 99.21%
251 $121 Million
Q2 2020

Aug 13, 2024
BUY
$493.32 - $643.92 $53,278 - $69,543
108 Added 71.05%
260 $162 Million
Q1 2020

Aug 13, 2024
BUY
$336.18 - $494.43 $35,971 - $52,904
107 Added 237.78%
152 $74.2 Million
Q1 2019

Aug 13, 2024
SELL
$372.08 - $439.57 $30,138 - $35,605
-81 Reduced 64.29%
45 $18.5 Million
Q2 2018

Aug 13, 2024
SELL
$284.6 - $344.99 $4.4 Million - $5.33 Million
-15,451 Reduced 99.71%
45 $15.5 Million
Q1 2018

Aug 14, 2024
SELL
$315.82 - $393.78 $25,581 - $31,896
-81 Reduced 64.29%
45 $15.5 Million
Q1 2018

Aug 13, 2024
BUY
$315.82 - $393.78 $4.88 Million - $6.08 Million
15,451 Added 34335.56%
15,496 $15.5 Million
Q3 2017

Aug 13, 2024
SELL
$431.38 - $504.0 $34,941 - $40,824
-81 Reduced 64.29%
45 $20.1 Million
Q4 2016

Aug 12, 2024
SELL
N/A
-81
45 $16.5 Million

Others Institutions Holding REGN

# of Institutions
1,461
Shares Held
84.5M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $124B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email